PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
87 hedge funds and large institutions have $213M invested in Progenics Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
15% less capital invested
Capital invested by funds: $251M → $213M (-$37.8M)
Holders
87
Holding in Top 10
–
Calls
$1.29M
Puts
$1.24M
Top Buyers
| 1 | +$6.49M | |
| 2 | +$4.09M | |
| 3 | +$3.03M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.12M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$2.07M |
Top Sellers
| 1 | -$7.22M | |
| 2 | -$1.62M | |
| 3 | -$831K | |
| 4 |
MCM
Moore Capital Management
New York
|
-$506K |
| 5 |
Millennium Management
New York
|
-$467K |